Quick response type heat-stable antibacterial and antiviral agent as well as preparation method and application thereof
Through the self-assembled antibacterial antiviral agent of composite particles, combined with the composite structure of TiO2, Cu2O and Ag, the thermal stability and response speed of antibacterial antiviral agents in the prior art are solved, and the bacteria and viruses are achieved at high temperatures Highly efficient inactivation and broad-spectrum effects.
Patent Information
- Application Number
- CN202411204973.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-08-30
AI Technical Summary
Existing antibacterial and antiviral agents cannot meet the requirements of rapid response sterilization and good thermal stability at the same time, especially in high-temperature melt spinning applications.
Micron-scale spheres formed by self-assembly of composite particles are used. The composite particles are composed of mixed-phase TiO2 nanoscale powder, Cu2O crystals and Ag nanoscale spheres. The thermal stability and antibacterial and antiviral effects of the material are ensured through the template-free method. .
A high-efficiency inactivation rate of bacteria and viruses within 5 minutes is achieved, and a low thermal weight loss is maintained above 330°C, meeting the temperature requirements of melt spinning, and providing broad-spectrum antibacterial and antiviral properties.
Smart Images

Figure CN119082906A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of preparation of antibacterial and antiviral agents, and relates to a fast-response thermally stable antibacterial and antiviral agent, a preparation method and application thereof. Background Art
[0002] In nature, bacteria, viruses and other microorganisms are widely distributed and are important pathogens that cause biological diseases. Their transmission between people causes the spread of infectious diseases. Among them, contact transmission is one of the main transmission routes of pathogenic microorganisms, especially for susceptible people who come into contact with daily necessities contaminated by infectious sources and become infected with diseases. Textiles, as common daily necessities, provide a suitable environment for microorganisms to attach and grow due to the large number of gaps formed by their special weaving structure and good heat preservation and moisture retention properties.
[0003] In terms of inhibiting the spread of diseases, textiles that can quickly kill microorganisms have significant advantages. For textiles contaminated with bacteria and viruses, if they can be efficiently killed in a short period of time, the chance of re-transmission can be greatly reduced, which is especially important for medical staff and susceptible people. However, there is relatively little research and development on antibacterial and antiviral agents with rapid response performance for melt spinning.
[0004] Existing inorganic antibacterial agents with high temperature resistance, such as the antibacterial agent disclosed in patent application CN117886608A, have a good inhibitory effect on Escherichia coli, which can reach more than 99%, but the SEM image shows that the powder is a nano-scale powder without a special surface structure, which may have the problem of easy agglomeration; the antibacterial agent disclosed in patent application CN114847279A has an antibacterial rate of more than 99.9% against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, but on the one hand, the material uses broken glass as a raw material, which may be irritating to the human body, and on the other hand, the particle size of the powder is greater than 10μm, which also limits the use of the material. In addition, the above patents do not specify their response time for antibacterial effects, and it is difficult to determine whether they can meet the use requirements of inhibiting the transmission of microorganisms from objects to humans.
[0005] Among organic antimicrobial agents, the quaternary ammonium antimicrobial agent used in the literature (J.Appl.Polym.Sci.2015,132,42702.) is coated on the surface of cellulose fibers, which can effectively inactivate Escherichia coli and Staphylococcus aureus within 10 minutes, but its organic antimicrobial agent causes thermal stability to be unguaranteed. The cellulose film material obtained by the treatment method of the literature (Macromol.Mater.Eng.2020,305,2000228.) has an inhibition rate of 99.45% on Staphylococcus aureus and 73.47% on Escherichia coli within 5 minutes, but according to the literature, the thermal decomposition of the material occurs at 232°C, and the heat loss is about 50% within 350°C. The heat resistance is poor and cannot meet the temperature requirements of melt spinning above 300°C.
[0006] In summary, the antibacterial and antiviral agents in the prior art cannot simultaneously meet the requirements of rapid response sterilization and good thermal stability. Summary of the invention
[0007] The purpose of the present invention is to solve the problems existing in the prior art and to provide a fast-response thermally stable antibacterial and antiviral agent and a preparation method and application thereof.
[0008] To achieve the above object, the technical solution adopted by the present invention is as follows:
[0009] A fast-response thermally stable antibacterial and antiviral agent, which is a micron-sized sphere formed by self-assembly of composite particles; the composite particles are composed of mixed-phase TiO2 nanopowder, Cu2O crystals, and Ag nanospheres, the mixed-phase TiO2 nanopowder is a mixture of anatase TiO2 nanopowder and rutile TiO2 nanopowder, the Cu2O crystals are in-situ grown on the surface of the mixed-phase TiO2 nanopowder, and the Ag nanospheres are embedded in and on the surface of the Cu2O crystals.
[0010] As the preferred technical solution:
[0011] The fast-response thermally stable antibacterial and antiviral agent as described above, the average particle sizes of the mixed phase TiO2 nanopowder, Cu2O crystal, Ag nanosphere, composite particles, and the fast-response thermally stable antibacterial and antiviral agent are 20-50 nm, 10-50 nm, 5-15 nm, 40-300 nm, and 0.6-1.5 μm, respectively;
[0012] In the fast-response thermally stable antibacterial and antiviral agent, the content of the mixed-phase TiO2 nanometer-scale powder is 20-40wt%, and the content of the Cu2O crystal is 40-60wt%.
[0013] The fast-response heat-stable antibacterial and antiviral agent as described above has an antibacterial rate of more than 95% against Escherichia coli and Staphylococcus aureus within 5 minutes, an antiviral rate of more than 92% against HCoV-OC43 and HCoV-229E viruses within 5 minutes, an antibacterial rate of more than 99% against Escherichia coli and Staphylococcus aureus within 30 minutes, an antiviral rate of more than 99% against HCoV-OC43 and HCoV-229E viruses within 30 minutes, and a thermal weight loss within 330°C of less than 5wt%.
[0014] The present invention also provides a method for preparing a fast-response thermally stable antibacterial and antiviral agent as described in any one of the above, wherein a template-free method is used to prepare a mixture of TiO2 nanopowder, alkali, Cu 2+ 、Ag + The reducing agent solution is added dropwise to the dispersion, and after the addition is completed, the mixture is stirred and reacted at 20-50° C. for 2-5 hours. After post-treatment (separation, washing, and drying at 50-80° C.), a fast-response thermally stable antibacterial and antiviral agent is obtained.
[0015] The present invention adopts a reducing agent to 2+ The mixed phase TiO2 nanopowder is introduced into the reaction solution as the nucleus of heterogeneous nucleation, inducing the growth of Cu2O crystals on the mixed phase TiO2 nanopowder. The Cu2O crystals and the mixed phase TiO2 nanopowder have a large contact area. 2+ During the reduction process, Ag + It is also synchronously reduced to Ag nanospheres, which are embedded in the interior and surface of Cu2O crystals to obtain composite particles. The composite particles have a tendency to self-assemble in the reaction solution because of their higher surface energy, so that the surface energy is reduced and they agglomerate with each other. During the agglomeration process, certain pores are opened between the particles, and finally a stable, fast-response, thermally stable antibacterial and antiviral agent is obtained.
[0016] Many documents, including (Small, 2023, 19 (26), 2300394.) and (Chemical Reviews, 2016, 116 (18): 10983-11060.), summarize and record the synthesis methods of micro-nanostructured particles. Among these methods, the template method is currently widely recognized. This method uses existing template agents such as polymers carrying functional groups that can react with metal ions to limit the directional growth of particle crystals, thereby forming micro-nanostructured particles that meet the requirements. However, the introduction of templates may bring some problems. On the one hand, it may affect the thermal stability of the particles, making the antibacterial and antiviral agents unable to meet the temperature requirements of melt spinning above 300°C; on the other hand, the template may dilute the effective antibacterial components in the antibacterial and antiviral agents, thereby damaging their antibacterial effects at the same addition amount and increasing the synthesis cost of the antibacterial and antiviral agents.
[0017] Although (Exploration, 2022, 2(5), 20210237.) and other literature have introduced methods for template-free synthesis of micro-nano structures, these methods have some limitations in practical applications. On the one hand, the synthesis conditions of such methods are relatively harsh, and often require a specific temperature or solvent environment to achieve effective synthesis of micro-nano structures; on the other hand, these methods are more often used to synthesize single-phase micro-nanostructure particles, that is, they are mainly suitable for the synthesis of particles with a single chemical composition. However, when trying to synthesize two-phase or even multi-phase particles such as TiO2 and Cu2O, these methods often face more limitations and challenges. Therefore, although the template-free synthesis of micro-nano structures has certain potential, there are still certain limitations in achieving the synthesis of complex particle structures.
[0018] In comparison, the present invention carries out the reaction in an aqueous environment at room temperature, which is mild and environmentally friendly. It is worth noting that the present invention does not use a large molecular weight organic template, which makes the product have good thermal stability. In this way, the present invention achieves the synthesis of an antibacterial and antiviral agent that can be used for melt spinning efficiently and at low cost.
[0019] As the preferred technical solution:
[0020] The method as described above comprises the following steps:
[0021] (1) Slowly add a copper salt solution and a silver salt solution to the alkaline solution in sequence, and stir and mix for 1 to 3 hours;
[0022] (2) After adding the mixed phase TiO2 nanopowder, stirring until the mixed phase TiO2 nanopowder is fully dispersed;
[0023] (3) Slowly drop the reducing agent solution, and after the dropwise addition is completed, stir the reaction at 20-50° C. for 2-5 hours, and obtain a fast-response thermally stable antibacterial and antiviral agent through post-treatment.
[0024] In the method described above, the concentrations of the alkaline solution, copper salt solution, silver salt solution, and reducing agent solution are 0.1-0.5M, 0.3-1.5M, 0.01-0.1M, and 0.5-2.0M, respectively;
[0025] The base is NaOH, KOH or ammonia water, the copper salt is copper acetate, copper nitrate or copper sulfate, the silver salt is silver nitrate, and the reducing agent is ascorbic acid, sodium sulfite or hydrazine hydrate;
[0026] The volume ratio of the alkaline solution, the copper salt solution, the silver salt solution and the reducing agent solution is 1:1:0.5-1.5:1.5-2, and the molar ratio of the mixed phase TiO2 nanometer powder and the copper salt is 1:2-5.
[0027] In the method described above, the stirring reaction is carried out at 0.1 MPa and the stirring rate is 200-500 rpm.
[0028] The present invention also provides the use of a fast-response thermally stable antibacterial and antiviral agent as described in any one of the above items, which is used as an additive for melt spinning.
[0029] As the preferred technical solution:
[0030] For the application as described above, the specific process is: firstly, the fast-response heat-stable antibacterial and antiviral agent is melt-blended with the polymer powder to make an antibacterial masterbatch, and then the antibacterial masterbatch and the polymer chips are melt-spun to make the antibacterial and antiviral fiber.
[0031] In the application as described above, the polymer powder and the polymer slices are made of the same material, PET or PA6; in the antibacterial masterbatch, the content of the fast-response heat-stable antibacterial and antiviral agent is 30wt%; in the antibacterial and antiviral fiber, the content of the fast-response heat-stable antibacterial and antiviral agent is 1.6-5wt%.
[0032] Principle of the invention:
[0033] The fast-response heat-stable antibacterial and antiviral agent of the present invention can meet the requirements of fast-response sterilization for the following reasons:
[0034] (1) TiO2 is the first N-type semiconductor to be studied. However, TiO2 semiconductor has a wide excitation band gap and can only be excited by ultraviolet light with higher energy, and has poor utilization of visible light. Cu2O is a rare P-type semiconductor that can be excited under visible light. Precious metal nanoparticles such as Ag have the SPR effect. Its presence can expand the utilization range of semiconductor materials for sunlight, extend light absorption from ultraviolet light to visible light and infrared light, and enhance the photocatalytic effect. The combination of the three can form a PN junction structure with a high response rate to sunlight at the contact interface between TiO2 and Cu2O, and reduce the excitation band gap of the PN junction by Ag, so that the material can have a better photocatalytic effect under irradiation with lower energy light. Specifically, this PN junction will produce directional carrier migration under sunlight irradiation, and the negative charge in the N region will be transferred to the P region (Cu2O region) and induce the production of free radicals that are destructive to pathogenic microorganisms in the P region, thereby enhancing the original antibacterial properties of inorganic antibacterial and antiviral agents.
[0035] (2) The present invention adopts mixed-phase TiO2 nanopowder as the nucleus for heterogeneous nucleation of Cu2O. Compared with pure anatase TiO2 nanopowder or rutile TiO2 nanopowder, the mixed-phase TiO2 nanopowder has a mixed structure, which increases the defect density in the TiO2 lattice, increases the concentration of carriers, and increases the number of electrons and holes, making it have a stronger ability to capture solution components on the TiO2 surface, and has excellent ultraviolet absorption, photocatalytic sterilization, decomposition of organic pollutants and other properties. And because of the nanostructure of the particles themselves, the specific surface area is larger, and the irregular mixed phase structure makes the growth sites on the surface easy for crystal attachment unevenly distributed, so that the Cu2O crystals choose suitable sites on the TiO2 surface to grow relatively irregularly, and it is not easy to completely cover the original TiO2. Both TiO2 and Cu2O can be exposed to participate in the photocatalytic process, and the original antibacterial and photothermal conversion capabilities of TiO2 can be fully exerted. For example, the photothermal conversion of TiO2 is by absorbing infrared light and converting it into heat energy, but the infrared light energy is low and the penetration ability is poor. Actively exposing TiO2 from Cu2O can also improve the effect of TiO2 photothermal conversion. In addition, Cu2O crystals grow in situ on the surface of the mixed phase TiO2 nanopowder, and the two have a relatively large contact area, which is difficult to achieve by simple physical blending or simultaneous growth of two phases. The larger the contact area, the easier it is for PN junction charge transfer to occur, the more active free radicals are generated by catalysis, and the better the photocatalytic antibacterial effect.
[0036] (3) The micron-sized spheres of the present invention are formed by self-assembly of composite particles. The composite particles are arranged non-densely during the self-assembly process and there is a certain amount of space between them, so that a large number of large-pore-sized gaps are formed on the surface of the antibacterial and antiviral agent (which can be observed based on scanning electron microscope images), which can embed and fix viruses, providing more sufficient space for virus enrichment.
[0037] (4) The composite photothermal antibacterial and antiviral agent of the present invention has a surface concave-convex structure, which helps to further adhere to the virus and exert a more effective antiviral effect.
[0038] (5) Ag, Ti, and Cu elements all have certain antibacterial effects. When used in combination, they can enhance the broad-spectrum antibacterial properties of antibacterial and antiviral agents. Existing literature has shown that Ag nanoparticles (Molecules, 2011, 16(10):8894-8918.) and Cu2O (ChemPlusChem, 2020, 85(9):1949-2206.) also have inhibitory effects on viruses.
[0039] (6) TiO2 has a photothermal conversion effect. It can absorb infrared light and convert it into heat, causing the temperature to rise and inhibiting the growth and reproduction of bacteria.
[0040] At the same time, the fast-response thermally stable antibacterial and antiviral agent of the present invention can meet the requirements of melt spinning because: ① The present invention does not use a large molecular weight organic template in the process of preparing the fast-response thermally stable antibacterial and antiviral agent, which makes the product have better thermal stability; ② The particle size of the composite photothermal antibacterial and antiviral agent is uniform and controllable; ③ The composite photothermal antibacterial and antiviral agent has relatively good compatibility with the polymer matrix and will not have a significant impact on the mechanical properties of the fiber.
[0041] Beneficial effects:
[0042] The present invention constructs a composite antibacterial and antiviral agent that can respond quickly by superimposing the original antibacterial and antiviral effects of the antibacterial and antiviral agent, the PN junction photocatalytic generation of active free radicals, and the TiO2 photothermal effect antibacterial effect, and constructs a micro-nano structure in morphology. It can not only respond quickly and kill bacteria, but also has a good inhibitory effect on viruses, and at the same time has good thermal stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Figure 1 This is a SEM image of the fast-response thermally stable antibacterial and antiviral agent prepared in Example 3;
[0044] Figure 2 This is a SEM image of the fast-response thermally stable antibacterial and antiviral agent prepared in Example 4;
[0045] Figure 3This is a SEM image of the fast-response thermally stable antibacterial and antiviral agent prepared in Example 2;
[0046] Figure 4 This is a SEM image of the fast-response thermally stable antibacterial and antiviral agent prepared in Example 5;
[0047] Figure 5 This is the SEM image of the fast-response thermally stable antibacterial and antiviral agent prepared in Example 1. DETAILED DESCRIPTION
[0048] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.
[0049] The testing methods of the relevant performance indicators in the following embodiments are as follows:
[0050] Antibacterial rate: tested in accordance with GB / T 21510-2008 standard.
[0051] Antiviral rate: Tested in accordance with ISO 18184-2019 standard.
[0052] Thermal weight loss of fast-response heat-stable antibacterial and antiviral agents within 330°C: tested using TG209F1 NETZSCH thermogravimetric analyzer under nitrogen atmosphere; the purge gas rate was 40 mL / min, the protective gas rate was 20 mL / min, the heating rate was 10°C / min, and the actual test range was 30-700°C.
[0053] Example 1
[0054] A method for preparing a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0055] (1) Preparation of raw materials;
[0056] Alkaline solution: the solute is NaOH, the solvent is water, and the concentration is 0.2M;
[0057] Copper salt solution: the solute is copper acetate, the solvent is water, and the concentration is 0.3M;
[0058] Silver salt solution: the solute is silver nitrate, the solvent is water, and the concentration is 0.01M;
[0059] Mixed phase TiO2 nanopowder: fumed titanium dioxide, manufactured by Evonik Degussa, Germany, model AEROXIDE P25;
[0060] Reducing agent solution: the solute is ascorbic acid, the solvent is water, and the concentration is 0.5M;
[0061] (2) Preparation of a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0062] (2.1) Slowly add copper salt solution and silver salt solution to the alkaline solution in sequence, and stir to mix for 3 hours;
[0063] (2.2) After adding the mixed phase TiO2 nanopowder into the system, stirring until the mixed phase TiO2 nanopowder is fully dispersed;
[0064] (2.3) Slowly drop the reducing agent solution into the system, and after the dropwise addition, stir the reaction at 0.1 MPa and 20° C. at a speed of 200 rpm for 3 h. After post-treatment (separation, washing, and drying at 60° C.), a fast-response thermally stable antibacterial and antiviral agent is obtained;
[0065] The volume ratio of the alkaline solution, the copper salt solution, the silver salt solution and the reducing agent solution is 1:1:0.5:1.5, and the molar ratio of the mixed phase TiO2 nanopowder and the copper salt is 1:2.
[0066] The scanning electron microscopy image of the finally prepared fast-response thermally stable antibacterial and antiviral agent is as follows: Figure 5 As shown, the fast-response thermally stable antibacterial and antiviral agent is a micron-sized sphere formed by self-assembly of composite particles; the composite particles are composed of mixed-phase TiO2 nanopowder, Cu2O crystals, and Ag nanospheres, the Cu2O crystals are in-situ grown on the surface of the mixed-phase TiO2 nanopowder, and the Ag nanospheres are embedded in the interior and surface of the Cu2O crystals;
[0067] The average particle size of the mixed-phase TiO2 nanopowder is 20nm, the average particle size of the Cu2O crystal is 10nm, the average particle size of the Ag nanosphere is 5nm, the average particle size of the composite particle is 40nm, and the average particle size of the fast-response thermally stable antibacterial and antiviral agent is 1.2μm; in the fast-response thermally stable antibacterial and antiviral agent, the content of the mixed-phase TiO2 nanopowder is 20wt%, and the content of the Cu2O crystal is 40wt%;
[0068] The rapid response type heat-stable antibacterial and antiviral agent has an antibacterial rate of 99.8% against Escherichia coli within 5 minutes, and an antibacterial rate of 99.6% against Staphylococcus aureus; the rapid response type heat-stable antibacterial and antiviral agent has an antiviral rate of 96.6% against HCoV-OC43 virus within 5 minutes, and an antiviral rate of 94.4% against HCoV-229E virus;
[0069] The antibacterial rate of the fast-response heat-stable antibacterial and antiviral agent against Escherichia coli within 30 minutes is 99.9%, and the antibacterial rate against Staphylococcus aureus is 99.9%; the antiviral rate of the fast-response heat-stable antibacterial and antiviral agent against HCoV-OC43 virus within 30 minutes is 99.9%, and the antiviral rate against HCoV-229E virus is 99.9%; the thermal weight loss of the fast-response heat-stable antibacterial and antiviral agent within 330°C is 4.22wt%.
[0070] An application of a fast-response heat-stable antibacterial and antiviral agent, firstly melt-blending the fast-response heat-stable antibacterial and antiviral agent prepared in this embodiment with PET (manufacturer is Sinopec Yizheng Chemical Fiber Co., Ltd., model number is FG600) powder to prepare an antibacterial masterbatch, and then melt-spinning the antibacterial masterbatch and PET (manufacturer is Sinopec Yizheng Chemical Fiber Co., Ltd., model number is FD501) slices to prepare antibacterial and antiviral fibers; wherein the content of the fast-response heat-stable antibacterial and antiviral agent in the antibacterial masterbatch is 30wt%; melt-blending The process parameters are: screw zone 1 temperature 230℃, zone 2 temperature 245℃, zone 3 temperature 260℃, zone 4 temperature 255℃, zone 5 temperature 255℃, zone 6 temperature 255℃, zone 7 temperature 255℃; head temperature control 260℃; melt spinning process parameters are: screw zone 1 temperature 285℃, zone 2 temperature 297℃, zone 3 temperature 290℃, zone 4 temperature 292℃; one roller winding speed 900m / min, one roller temperature 60℃; two roller winding speed 1800m / min, two roller temperature 60℃.
[0071] The content of the fast-response thermally stable antibacterial and antiviral agent in the finally prepared antibacterial and antiviral fiber is 3.2 wt %.
[0072] Example 2
[0073] A method for preparing a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0074] (1) Preparation of raw materials;
[0075] Alkaline solution: the solute is NaOH, the solvent is water, and the concentration is 0.2M;
[0076] Copper salt solution: the solute is copper sulfate, the solvent is water, and the concentration is 0.3M;
[0077] Silver salt solution: the solute is silver nitrate, the solvent is water, and the concentration is 0.01M;
[0078] Mixed phase TiO2 nanopowder: fumed titanium dioxide, manufactured by Evonik Degussa, Germany, model AEROXIDE P25;
[0079] Reducing agent solution: the solute is ascorbic acid, the solvent is water, and the concentration is 0.5M;
[0080] (2) Preparation of a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0081] (2.1) Slowly add copper salt solution and silver salt solution to the alkaline solution in sequence, and stir to mix for 3 hours;
[0082] (2.2) After adding the mixed phase TiO2 nanopowder into the system, stirring until the mixed phase TiO2 nanopowder is fully dispersed;
[0083] (2.3) Slowly drop the reducing agent solution into the system, and after the dropwise addition, stir the mixture at 0.1 MPa and 40° C. at a speed of 200 rpm for 3 h. After post-treatment (separation, washing, and drying at 60° C.), a fast-response thermally stable antibacterial and antiviral agent is obtained;
[0084] The volume ratio of the alkaline solution, the copper salt solution, the silver salt solution and the reducing agent solution is 1:1:0.5:1.5, and the molar ratio of the mixed phase TiO2 nanopowder and the copper salt is 1:2.
[0085] The scanning electron microscopy image of the finally prepared fast-response thermally stable antibacterial and antiviral agent is as follows: Figure 3 As shown, the fast-response thermally stable antibacterial and antiviral agent is a micron-sized sphere formed by self-assembly of composite particles; the composite particles are composed of mixed-phase TiO2 nanopowder, Cu2O crystals, and Ag nanospheres, the Cu2O crystals are in-situ grown on the surface of the mixed-phase TiO2 nanopowder, and the Ag nanospheres are embedded in the interior and surface of the Cu2O crystals;
[0086] The average particle size of the mixed-phase TiO2 nano-powder is 20nm, the average particle size of the Cu2O crystal is 50nm, the average particle size of the Ag nano-sphere is 5nm, the average particle size of the composite particles is 240nm, and the average particle size of the fast-response thermally stable antibacterial and antiviral agent is 0.6μm; in the fast-response thermally stable antibacterial and antiviral agent, the content of the mixed-phase TiO2 nano-powder is 30wt%, and the content of the Cu2O crystal is 50wt%;
[0087] The rapid response type heat-stable antibacterial and antiviral agent has an antibacterial rate of 99.8% against Escherichia coli within 5 minutes, and an antibacterial rate of 97.6% against Staphylococcus aureus; the rapid response type heat-stable antibacterial and antiviral agent has an antiviral rate of 92.1% against HCoV-OC43 virus within 5 minutes, and an antiviral rate of 92% against HCoV-229E virus;
[0088] The antibacterial rate of the fast-response heat-stable antibacterial and antiviral agent against Escherichia coli within 30 minutes is 99.9%, and the antibacterial rate against Staphylococcus aureus is 99.9%; the antiviral rate of the fast-response heat-stable antibacterial and antiviral agent against HCoV-OC43 virus within 30 minutes is 99.8%, and the antiviral rate against HCoV-229E virus is 99.7%; the thermal weight loss of the fast-response heat-stable antibacterial and antiviral agent within 330°C is 1.44wt%.
[0089] An application of a fast-response heat-stable antibacterial and antiviral agent, firstly melt-blending the fast-response heat-stable antibacterial and antiviral agent prepared in this embodiment with PET (manufacturer is Sinopec Yizheng Chemical Fiber Co., Ltd., model number is FG600) powder to prepare an antibacterial masterbatch, and then melt-spinning the antibacterial masterbatch and PET (manufacturer is Sinopec Yizheng Chemical Fiber Co., Ltd., model number is FD501) slices to prepare an antibacterial and antiviral fiber; wherein the content of the fast-response heat-stable antibacterial and antiviral agent in the antibacterial masterbatch is 30wt%; the melt-blended The process parameters are: screw zone 1 temperature 230℃, zone 2 temperature 245℃, zone 3 temperature 260℃, zone 4 temperature 255℃, zone 5 temperature 255℃, zone 6 temperature 255℃, zone 7 temperature 255℃; head temperature control 260℃; melt spinning process parameters are: screw zone 1 temperature 285℃, zone 2 temperature 297℃, zone 3 temperature 290℃, zone 4 temperature 292℃; one roller winding speed 900m / min, one roller temperature 60℃; two roller winding speed 1800m / min, two roller temperature 60℃.
[0090] The content of the fast-response thermally stable antibacterial and antiviral agent in the finally prepared antibacterial and antiviral fiber is 3.2 wt %.
[0091] Example 3
[0092] A method for preparing a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0093] (1) Preparation of raw materials;
[0094] Alkaline solution: the solute is NaOH, the solvent is water, and the concentration is 0.3M;
[0095] Copper salt solution: the solute is copper nitrate, the solvent is water, and the concentration is 1.5M;
[0096] Silver salt solution: the solute is silver nitrate, the solvent is water, and the concentration is 0.05M;
[0097] Mixed phase TiO2 nanopowder: nano titanium dioxide, manufacturer is Hangzhou Hengna New Materials Co., Ltd., model number is HN-J25;
[0098] Reducing agent solution: the solute is sodium sulfite, the solvent is water, and the concentration is 2.0M;
[0099] (2) Preparation of a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0100] (2.1) Slowly add copper salt solution and silver salt solution to the alkaline solution in sequence, and stir to mix for 1 hour;
[0101] (2.2) After adding the mixed phase TiO2 nanopowder into the system, stirring until the mixed phase TiO2 nanopowder is fully dispersed;
[0102] (2.3) Slowly drop the reducing agent solution into the system, and after the dropwise addition is completed, stir the reaction at 0.1 MPa and 20° C. at a speed of 350 rpm for 5 h, and obtain a fast-response thermally stable antibacterial and antiviral agent after post-treatment (separation, washing, and drying at 80° C.);
[0103] The volume ratio of the alkaline solution, the copper salt solution, the silver salt solution and the reducing agent solution is 1:1:1.5:2, and the molar ratio of the mixed phase TiO2 nanopowder and the copper salt is 1:5.
[0104] The scanning electron microscopy image of the finally prepared fast-response thermally stable antibacterial and antiviral agent is as follows: Figure 1 As shown, micron-scale spheres are formed by self-assembly of composite particles; the composite particles are composed of mixed-phase TiO2 nanopowder, Cu2O crystals, and Ag nanospheres, the Cu2O crystals are in-situ grown on the surface of the mixed-phase TiO2 nanopowder, and the Ag nanospheres are embedded in the interior and surface of the Cu2O crystals;
[0105] The average particle size of the mixed-phase TiO2 nanopowder is 25nm, the average particle size of the Cu2O crystal is 20nm, the average particle size of the Ag nanosphere is 7nm, the average particle size of the composite particles is 160nm, and the average particle size of the fast-response thermally stable antibacterial and antiviral agent is 0.9μm; in the fast-response thermally stable antibacterial and antiviral agent, the content of the mixed-phase TiO2 nanopowder is 40wt%, and the content of the Cu2O crystal is 40wt%;
[0106] The rapid response type heat-stable antibacterial and antiviral agent has an antibacterial rate of 95.9% against Escherichia coli within 5 minutes, and an antibacterial rate of 96.4% against Staphylococcus aureus; the rapid response type heat-stable antibacterial and antiviral agent has an antiviral rate of 93.2% against HCoV-OC43 virus within 5 minutes, and an antiviral rate of 95.4% against HCoV-229E virus;
[0107] The antibacterial rate of the fast-response heat-stable antibacterial and antiviral agent against Escherichia coli within 30 minutes is 99.8%, and the antibacterial rate against Staphylococcus aureus is 99.5%; the antiviral rate of the fast-response heat-stable antibacterial and antiviral agent against HCoV-OC43 virus within 30 minutes is 99.6%, and the antiviral rate against HCoV-229E virus is 99.6%; the thermal weight loss of the fast-response heat-stable antibacterial and antiviral agent within 330°C is 3.02wt%.
[0108] An application of a fast-response heat-stable antibacterial and antiviral agent, firstly melt-blending the fast-response heat-stable antibacterial and antiviral agent prepared in this embodiment with PA6 (manufacturer is DuPont, brand name is PA6 ST7301 NC010) powder to prepare an antibacterial masterbatch, and then melt-blending the antibacterial masterbatch with PA6 (manufacturer is DuPont, brand name is PA6 7304NC010) slices are melt-spun to make antibacterial and antiviral fibers; wherein, in the antibacterial masterbatch, the content of the fast-response thermally stable antibacterial and antiviral agent is 30wt%; the process parameters of melt blending are: screw zone 1 temperature 210°C, zone 2 temperature 225°C, zone 3 temperature 240°C, zone 4 temperature 235°C, zone 5 temperature 235°C, zone 6 temperature 235°C, zone 7 temperature 235°C; head temperature control 240°C; melt spinning process parameters are: screw zone 1 temperature 266°C, zone 2 temperature 282°C, zone 3 temperature 272°C, zone 4 temperature 270°C; one roller winding speed 1500m / min, one roller temperature 60°C; two roller winding speed 3000m / min, two roller temperature 120°C.
[0109] The content of the fast-response thermally stable antibacterial and antiviral agent in the finally prepared antibacterial and antiviral fiber is 5wt%.
[0110] Comparative Example 1
[0111] A method for preparing an antibacterial and antiviral agent is basically the same as Example 3, except that the mixed phase TiO2 nanopowder is replaced with anatase TiO2 nanopowder of equal mass (manufacturer: Hangzhou Hengna New Materials Co., Ltd., model: HN-TA18).
[0112] The antibacterial and antiviral agents had an antibacterial rate of 77.2% against Escherichia coli and 72.0% against Staphylococcus aureus within 5 minutes; the antibacterial and antiviral agents had an antiviral rate of 47.6% against HCoV-OC43 and 64.6% against HCoV-229E within 5 minutes;
[0113] The antibacterial and antiviral agents had an antibacterial rate of 95.0% against Escherichia coli and 94.2% against Staphylococcus aureus within 30 minutes; the antiviral rate of the antibacterial and antiviral agents against HCoV-OC43 virus and 85.3% against HCoV-229E virus within 30 minutes.
[0114] Comparative Example 2
[0115] A method for preparing an antibacterial and antiviral agent is basically the same as Example 3, except that the mixed-phase TiO2 nanopowder is replaced with an equal mass of rutile TiO2 nanopowder (manufacturer is Hangzhou Hengna New Materials Co., Ltd., model number is HN-T25).
[0116] The antibacterial and antiviral agents had an antibacterial rate of 82.3% against Escherichia coli and 79.9% against Staphylococcus aureus within 5 minutes; the antiviral rate of the antibacterial and antiviral agents against HCoV-OC43 virus and 59.2% against HCoV-229E virus within 5 minutes;
[0117] The antibacterial and antiviral agent had an antibacterial rate of 95.2% against Escherichia coli within 30 minutes, and an antibacterial rate of 97.7% against Staphylococcus aureus; the antiviral rate of the antibacterial and antiviral agent against HCoV-OC43 virus within 30 minutes was 87.5%, and the antiviral rate against HCoV-229E virus was 85.1%.
[0118] Compared with Example 3, the antibacterial and antiviral rates of the antibacterial and antiviral agents of Comparative Examples 1 and 2 within 5 minutes are significantly reduced. This is because pure anatase TiO2 nanopowder is used in Comparative Example 1, and pure rutile TiO2 nanopowder is used in Comparative Example 2. The single crystal structure makes the defect density in the TiO2 lattice smaller, the carrier concentration is reduced, and the number of electrons and holes is reduced, thereby weakening the ability to capture solution components on the TiO2 surface, and the performance of ultraviolet absorption, photocatalytic sterilization, and decomposition of organic pollutants is reduced; at the same time, since it is not The mixed phase structure has a relatively small specific surface area of the particles, and the distribution of surface growth sites is relatively regular, which makes it easy for Cu2O crystals to completely cover the original TiO2 when growing on the TiO2 surface, resulting in TiO2 and Cu2O not being fully exposed to participate in the photocatalytic process, and thus the original antibacterial and photothermal conversion capabilities of TiO2 cannot be fully exerted; in addition, the contact area between the single crystal TiO2 nanopowder and the Cu2O crystal during in-situ growth is relatively small, the PN junction charge transfer is difficult to occur, the active free radicals generated by catalysis are reduced, and the photocatalytic antibacterial effect is poor.
[0119] Example 4
[0120] A method for preparing a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0121] (1) Preparation of raw materials;
[0122] Alkaline solution: the solute is KOH, the solvent is water, and the concentration is 0.1M;
[0123] Copper salt solution: the solute is copper sulfate, the solvent is water, and the concentration is 1.5M;
[0124] Silver salt solution: the solute is silver nitrate, the solvent is water, and the concentration is 0.1M;
[0125] Mixed phase TiO2 nanopowder: fumed titanium dioxide, manufactured by Hubei Huifu Nanomaterials Co., Ltd., model NT-50;
[0126] Reducing agent solution: the solute is ascorbic acid, the solvent is water, and the concentration is 2.0M;
[0127] (2) Preparation of a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0128] (2.1) Slowly add copper salt solution and silver salt solution to the alkaline solution in sequence, and stir to mix for 2 h;
[0129] (2.2) After adding the mixed phase TiO2 nanopowder into the system, stirring until the mixed phase TiO2 nanopowder is fully dispersed;
[0130] (2.3) Slowly drop the reducing agent solution into the system, and after the dropwise addition, stir the reaction at 0.1 MPa and 20° C. at a speed of 500 rpm for 3 h. After post-treatment (separation, washing, and drying at 50° C.), a fast-response thermally stable antibacterial and antiviral agent is obtained;
[0131] The volume ratio of the alkaline solution, the copper salt solution, the silver salt solution and the reducing agent solution is 1:1:0.5:2, and the molar ratio of the mixed phase TiO2 nanopowder and the copper salt is 1:5.
[0132] The scanning electron microscopy image of the finally prepared fast-response thermally stable antibacterial and antiviral agent is as follows: Figure 2 As shown, the fast-response thermally stable antibacterial and antiviral agent is a micron-sized sphere formed by self-assembly of composite particles; the composite particles are composed of mixed-phase TiO2 nanopowder, Cu2O crystals, and Ag nanospheres, the Cu2O crystals are in-situ grown on the surface of the mixed-phase TiO2 nanopowder, and the Ag nanospheres are embedded in the interior and surface of the Cu2O crystals;
[0133] The average particle size of the mixed-phase TiO2 nanopowder is 50nm, the average particle size of the Cu2O crystal is 40nm, the average particle size of the Ag nanosphere is 15nm, the average particle size of the composite particle is 300nm, and the average particle size of the fast-response thermally stable antibacterial and antiviral agent is 1.5μm; in the fast-response thermally stable antibacterial and antiviral agent, the content of the mixed-phase TiO2 nanopowder is 30wt%, and the content of the Cu2O crystal is 60wt%;
[0134] The rapid response type heat-stable antibacterial and antiviral agent has an antibacterial rate of 96.1% against Escherichia coli within 5 minutes, and an antibacterial rate of 96.5% against Staphylococcus aureus; the rapid response type heat-stable antibacterial and antiviral agent has an antiviral rate of 96.4% against HCoV-OC43 virus within 5 minutes, and an antiviral rate of 97.8% against HCoV-229E virus;
[0135] The antibacterial rate of the fast-response heat-stable antibacterial and antiviral agent against Escherichia coli within 30 minutes is 99.5%, and the antibacterial rate against Staphylococcus aureus is 99.2%; the antiviral rate of the fast-response heat-stable antibacterial and antiviral agent against HCoV-OC43 virus within 30 minutes is 99.8%, and the antiviral rate against HCoV-229E virus is 99.2%; the thermal weight loss of the fast-response heat-stable antibacterial and antiviral agent within 330°C is 1.65wt%.
[0136] An application of a fast-response heat-stable antibacterial and antiviral agent, firstly melt-blending the fast-response heat-stable antibacterial and antiviral agent prepared in this embodiment with PA6 (manufacturer is DuPont, brand name is PA6 ST7301 NC010) powder to prepare an antibacterial masterbatch, and then melt-blending the antibacterial masterbatch with PA6 (manufacturer is DuPont, brand name is PA6 7304NC010) slices are melt-spun to make antibacterial and antiviral fibers; wherein, in the antibacterial masterbatch, the content of the fast-response thermally stable antibacterial and antiviral agent is 30wt%; the process parameters of melt blending are: screw zone 1 temperature 210°C, zone 2 temperature 225°C, zone 3 temperature 240°C, zone 4 temperature 235°C, zone 5 temperature 235°C, zone 6 temperature 235°C, zone 7 temperature 235°C; head temperature control 240°C; melt spinning process parameters are: screw zone 1 temperature 266°C, zone 2 temperature 278°C, zone 3 temperature 268°C, zone 4 temperature 266°C; one roller winding speed 1500m / min, one roller temperature 60°C; two roller winding speed 3000m / min, two roller temperature 120°C.
[0137] The content of the fast-response thermally stable antibacterial and antiviral agent in the finally prepared antibacterial and antiviral fiber is 1.6 wt %.
[0138] Example 5
[0139] A method for preparing a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0140] (1) Preparation of raw materials;
[0141] Alkaline solution: the solute is ammonia water, the solvent is water, and the concentration is 0.5M;
[0142] Copper salt solution: the solute is copper acetate, the solvent is water, and the concentration is 0.3M;
[0143] Silver salt solution: the solute is silver nitrate, the solvent is water, and the concentration is 0.05M;
[0144] Mixed phase TiO2 nanopowder: nano titanium dioxide, manufacturer is Hangzhou Hengna New Materials Co., Ltd., model number is HN-J25;
[0145] Reducing agent solution: the solute is hydrazine hydrate, the solvent is water, and the concentration is 1.0M;
[0146] (2) Preparation of a fast-response thermally stable antibacterial and antiviral agent, the specific steps are as follows:
[0147] (2.1) Slowly add copper salt solution and silver salt solution to the alkaline solution in sequence, and stir to mix for 1 hour;
[0148] (2.2) After adding the mixed phase TiO2 nanopowder into the system, stirring until the mixed phase TiO2 nanopowder is fully dispersed;
[0149] (2.3) Slowly drop the reducing agent solution into the system, and after the dropwise addition is completed, stir the reaction at 0.1 MPa and 50° C. at a speed of 350 rpm for 2 h, and obtain a fast-response thermally stable antibacterial and antiviral agent after post-treatment (separation, washing, and drying at 80° C.);
[0150] Among them, the volume ratio of the alkaline solution, the copper salt solution, the silver salt solution and the reducing agent solution is 1:1:1:1.5, and the molar ratio of the mixed phase TiO2 nanopowder and the copper salt is 1:2.
[0151] The scanning electron microscopy image of the finally prepared fast-response thermally stable antibacterial and antiviral agent is as follows: Figure 4 As shown, the fast-response thermally stable antibacterial and antiviral agent is a micron-sized sphere formed by self-assembly of composite particles; the composite particles are composed of mixed-phase TiO2 nanopowder, Cu2O crystals, and Ag nanospheres, the Cu2O crystals are in-situ grown on the surface of the mixed-phase TiO2 nanopowder, and the Ag nanospheres are embedded in the interior and surface of the Cu2O crystals;
[0152] The average particle size of the mixed-phase TiO2 nano-scale powder is 25nm, the average particle size of the Cu2O crystal is 10nm, the average particle size of the Ag nano-scale sphere is 10nm, the average particle size of the composite particle is 120nm, and the average particle size of the fast-response thermally stable antibacterial and antiviral agent is 0.7μm; in the fast-response thermally stable antibacterial and antiviral agent, the content of the mixed-phase TiO2 nano-scale powder is 40wt%, and the content of the Cu2O crystal is 40wt%;
[0153] The rapid response type heat-stable antibacterial and antiviral agent has an antibacterial rate of 99.5% against Escherichia coli within 5 minutes, and an antibacterial rate of 96.5% against Staphylococcus aureus; the rapid response type heat-stable antibacterial and antiviral agent has an antiviral rate of 93.5% against HCoV-OC43 virus within 5 minutes, and an antiviral rate of 92.8% against HCoV-229E virus;
[0154] The antibacterial rate of the fast-response heat-stable antibacterial and antiviral agent against Escherichia coli within 30 minutes is 99.7%, and the antibacterial rate against Staphylococcus aureus is 99.5%; the antiviral rate of the fast-response heat-stable antibacterial and antiviral agent against HCoV-OC43 virus within 30 minutes is 99.7%, and the antiviral rate against HCoV-229E virus is 99.3%; the thermal weight loss of the fast-response heat-stable antibacterial and antiviral agent within 330°C is 4.86wt%.
[0155] An application of a fast-response heat-stable antibacterial and antiviral agent, firstly melt-blending the fast-response heat-stable antibacterial and antiviral agent prepared in this embodiment with PET (manufacturer is Sinopec Yizheng Chemical Fiber Co., Ltd., model number is FG720) powder to prepare an antibacterial masterbatch, and then melt-spinning the antibacterial masterbatch and PET (manufacturer is Sinopec Yizheng Chemical Fiber Co., Ltd., model number is FD502) slices to prepare an antibacterial and antiviral fiber; wherein the content of the fast-response heat-stable antibacterial and antiviral agent in the antibacterial masterbatch is 30wt%; the melt-blended The process parameters are: screw zone 1 temperature 230℃, zone 2 temperature 245℃, zone 3 temperature 260℃, zone 4 temperature 255℃, zone 5 temperature 255℃, zone 6 temperature 255℃, zone 7 temperature 255℃; head temperature control 260℃; melt spinning process parameters are: screw zone 1 temperature 285℃, zone 2 temperature 296℃, zone 3 temperature 290℃, zone 4 temperature 290℃; one roller winding speed 900m / min, one roller temperature 80℃; two roller winding speed 1800m / min, two roller temperature 160℃.
[0156] The content of the fast-response thermally stable antibacterial and antiviral agent in the finally prepared antibacterial and antiviral fiber is 1.6 wt %.
Claims
1. A fast-response heat-stable antibacterial and antiviral agent, It is characterized in that It is a micron-sized sphere formed by self-assembly of composite particles; the composite particles are composed of mixed phase TiO 2 Nano-powder, Cu 2 O crystals, Ag nanospheres, mixed phase TiO 2 Nano-sized powder is anatase TiO 2 Nano-powder and rutile TiO 2 A mixture of nano-powders, Cu 2 O crystals grown in situ on mixed phase TiO 2 The surface of nanopowder, Ag nanospheres embedded in Cu 2 OThe interior and surface of the crystal.
2. A fast-response heat-stable antibacterial and antiviral agent according to claim 1, It is characterized in that Mixed phase TiO 2 Nano-powder, Cu 2 The average particle sizes of O crystals, Ag nanospheres, composite particles, and fast-response thermally stable antibacterial and antiviral agents are 20-50 nm, 10-50 nm, 5-15 nm, 40-300 nm, and 0.6-1.5 μm, respectively; Mixed phase TiO in fast-response thermally stable antibacterial and antiviral agents 2 The content of nano-powder is 20-40wt%, Cu 2 The content of O crystals is 40 to 60 wt%.
3. A fast-response heat-stable antibacterial and antiviral agent according to claim 1, It is characterized in that The fast-response heat-stable antibacterial and antiviral agent has an antibacterial rate of more than 95% against Escherichia coli and Staphylococcus aureus within 5 minutes, an antiviral rate of more than 92% against HCoV-OC43 and HCoV-229E viruses within 5 minutes, an antibacterial rate of more than 99% against Escherichia coli and Staphylococcus aureus within 30 minutes, and an antiviral rate of more than 99% against HCoV-OC43 and HCoV-229E viruses within 30 minutes. The thermal weight loss within 330°C is less than 5wt%.
4. A method for preparing a fast-response heat-stable antibacterial and antiviral agent as claimed in any one of claims 1 to 3, It is characterized in that To contain mixed phase TiO 2 Nano-powder, alkali, Cu 2+ 、Ag + The reducing agent solution is added dropwise to the dispersion, and after the addition is completed, the mixture is stirred and reacted at 20-50° C. for 2-5 hours. After post-treatment, a fast-response thermally stable antibacterial and antiviral agent is obtained.
5. The method according to claim 4, It is characterized in that The following steps are involved: (1) adding a copper salt solution and a silver salt solution dropwise to an alkaline solution, and stirring and mixing for 1 to 3 hours; (2) Adding mixed phase TiO 2 After the nano-sized powder is formed, stir until the mixed phase TiO 2 Nano-scale powders are fully dispersed; (3) adding a reducing agent solution dropwise, stirring and reacting at 20-50° C. for 2-5 hours, and obtaining a fast-response thermally stable antibacterial and antiviral agent through post-treatment.
6. The method according to claim 5, It is characterized in that The concentrations of the alkaline solution, copper salt solution, silver salt solution, and reducing agent solution are 0.1-0.5M, 0.3-1.5M, 0.01-0.1M, and 0.5-2.0M, respectively; The base is NaOH, KOH or ammonia water, the copper salt is copper acetate, copper nitrate or copper sulfate, the silver salt is silver nitrate, and the reducing agent is ascorbic acid, sodium sulfite or hydrazine hydrate; The volume ratio of the alkaline solution, copper salt solution, silver salt solution and reducing agent solution is 1:1:0.5~1.5:1.5~2, and the mixed phase TiO 2 The molar ratio of the nano-powder to the copper salt is 1:2-5.
7. The method according to claim 4, It is characterized in that The stirring reaction was carried out at 0.1 MPa and the stirring rate was 200-500 rpm.
8. Use of a fast-response heat-stable antibacterial and antiviral agent as claimed in any one of claims 1 to 3, It is characterized in that Used as an additive for melt spinning.
9. The use according to claim 8, It is characterized in that The specific process is: first, the fast-response heat-stable antibacterial and antiviral agent is melt-blended with the polymer powder to make an antibacterial masterbatch, and then the antibacterial masterbatch and polymer chips are melt-spun to make antibacterial and antiviral fibers.
10. The use according to claim 9, It is characterized in that The polymer powder and the polymer slices are made of the same material, PET or PA6; the content of the fast-response heat-stable antibacterial and antiviral agent in the antibacterial masterbatch is 30wt%; the content of the fast-response heat-stable antibacterial and antiviral agent in the antibacterial and antiviral fiber is 1.6-5wt%.
Citation Information
Patent Citations
TiO2@Ag / PVC (Poly Vinyl Chloride) composite antibacterial film and preparation method thereof
CN103102618A
Method for preparing PA6 (polyamide 6) / mesoporous nanometer material@Ag (silver) composite antibacterial fiber based on in-situ polymerizing method
CN108659525A
Preparation of nano-composite bactericidal and antiviral material and application thereof
CN112021340A
Preparation method and application of nano-copper antibacterial and antiviral functional master batch
CN115044073A
Cu2O / PA6 antibacterial fiber with self-assembled micro-nano structure and preparation method of Cu2O / PA6 antibacterial fiber
CN116949593A
Cited By
Photoresponse active material, preparation method thereof and nano-silver antibacterial master batch
CN121203178A
